Chemical screening of the leaves and flowers of Crataegus aronia resulted in the isolation of hyperoside, quercetin, rutin and β-sitosterol for the first time from this plant. The effects of the hydroethanolic extract of C. aronia (CAHE) on hypercholesterolemic rats were investigated. The rats, treated orally for four weeks with 400 mg/kg/day CAHE, exhibited significant decreases in serum total cholesterol (TC) and low-density lipoprotein (LDL). The results were compared with those obtained after oral administration of atorvastatin (10 mg/kg/day). Furthermore, 10-week daily co-administration of a high cholesterol diet and CAHE (200 mg/kg/day) prevented the increase in TC and LDL. These observations indicate that CAHE has a hypocholesterolemic effect.
RigelskyJM, SweetBV. (2002) Hawthorn: Pharmacology and therapeutic uses. American Journal of Health-System Pharmacy, 59, 417–422.
2.
LiH, SongF, XingJ, TsaoR, LiuZ, LiuS. (2009) Screening and structural characterization of α-glucosidase inhibitors from hawthorn leaf flavonoids extract by ultrafiltration LC-DAD-MSn and SORI-CID FTICR MS. Journal of the American Society for Mass Spectrometry, 20, 1496–1503.
3.
Al-EisawiDM. (1982) List of Jordan vascular plants. Mitteilungen Botanik Munchen, 18, 79–182.
4.
ZoharyM. (1966) Flora Palestina. Israel Academy of Sciences and Humanities, Jerusalem, Israel. 19–21.
5.
KhalilR, AbuharfeilN, ShabsougB. (2008) The effect of Crataegus aronia aqueous extract in rabbits fed with high cholesterol diet. European Journal of Scientific Research, 22, 352–360.
6.
HudaibM, MohammadM, BustanjiY, TayyemR, YousefM, AbuirjeieM, AburjaiT. (2008) Ethnopharmacological survey of medicinal plants in Jordan, Mujib Nature Reserve and surrounding area. Journal of Ethnopharmacology, 120, 63–71.
7.
LjubuncicP, PortnayaI, CoganU, AzaizehH, BomzonA. (2005) Antioxidant activity of Crataegus aronia aqueous extract used in traditional Arab medicine in Israel. Journal of Ethnopharmacology, 101,153-161.
8.
WagnerH, BladtS, ZgainskiEM. (1984) Plant Drug Analysis. Springer-Verlag, Berlin Germany. 299–304.
9.
MabryTJ, MarkhamKR, ThomasMB. (1970) The Systemic Identification of Flavonoids. Springer-Verlag, New York, USA, 41–61.
10.
GoadLJ, AkihisaY. (1997) Analysis of Sterols. Blackie Academic and Professional, London, UK. 376–380.
11.
AgrawalPK. (1989) Studies in Organic Chemistry 39: Carbon-13NMR of Flavonoids. Elsevier Science, Amsterdam, Holland. 154, 336–337, 341-342.
12.
BrodskyI, DennisLH, KahnSB, BradyLW. (1966) Normal mouse erythropoiesis: I. The role of the spleen in mouse erythropoiesis. Cancer Research, 26, 198–201.
13.
RussellDW. (1992) Cholesterol biosynthesis and metabolism. Cardiovascular Drugs and Therapy, 6, 103–110.
MashourNH, LinGI, FrishmanWH. (1998) Herbal medicine for the treatment of cardiovascular disease: Clinical considerations. Archives of Internal Medicine, 158, 2225–2234.
16.
RajendranS, DeepalakshmiPD, ParasakthyK, DevarjH, DevarajiSN. (1996) Effect of tincture of Crataegus on the LDL-receptor activity of hepatic plasma membrane of rats fed an atherogenic diet. Atherosclerosis, 123, 235–241.
17.
ZhangZ, HoWKK, HuangY, JamesAE, LamLW, ChenZ-Y. (2002) Hawthorn fruit is hypolipidemic in rabbits fed a high cholesterol diet. The Journal of Nutrition, 132, 5–10.
18.
ChenJD, WuYZ, TaoZL, ChenZM, LiuXP. (1995) Hawthorn (Shan Zha) drink and its lowering effect on blood lipid levels in humans and rats. World Review of Nutrition and Dietetics, 77, 147–154.
19.
DewickPM. (2002) Medicinal Natural Products. A Biosynthetic Approach. John Wiley & Sons Ltd, Toronto, Canada. 112–113.
20.
LiDY, ChenHJ, MehtaJL. (2001) Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. Cardiovascular Research, 52, 130–135.
21.
GinsbergHN. (2006) Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia. The Journal of Clinical Endocrinology and Metabolism, 91, 383–392.
22.
McTaggartF, JonesP. (2008) Effects of statins on high-density lipoproteins: A potential contribution to cardiovascular benefit. Cardiovascular Drugs and Therapy, 22, 321–338.
NguyenLB, SheferS, SalenG, TintGS, RuizF, BullockJ. (2001) Mechanisms for cholesterol homeostasis in rat jejunal mucosa: effects of cholesterol, sitosterol, and lovastatin. Journal of Lipid Research, 42,195-200.
25.
PanSY, YangR, DongH, YuZL, KoKM. (2006) Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet induced hypercholesterolemia in mice. European Journal of Pharmacology, 552, 170–175.
26.
AmmonHPT, HändelM. (1981) Crataegus, toxicology and pharmacology, part: I Toxicity. Planta Medica, 43, 105–120.
AmmonHPT, HändelM. (1981) Crataegus, toxicology and pharmacology. III: Pharmacodynamics and pharmacokinetcis. Planta Medica, 43, 313–322.
29.
PalmerWW. (1918) The colorimetric determination of hemoglobin. The Journal of Biological Chemistry, 33, 119–126.
30.
FriedewaldWT, LevyRI, FredricksonDS. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clinical Chemistry, 18, 499–502.
